[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583089":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":27,"centralContacts":34,"locations":43,"responsibleParty":62,"collaborators":21,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":67,"sex":73,"minAge":74,"maxAge":21,"enrollmentInfo":75,"targetDuration":21,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":89,"overallStatus":95,"whyStopped":21,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Istanbul University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ICG Fluorescence Imaging Group","EXPERIMENTAL","Women undergoing gynecologic oncology surgery with bowel resection and anastomosis. Anastomotic perfusion will be evaluated intraoperatively using indocyanine green (ICG) enhanced near-infrared fluorescence imaging.",[13,14],"Drug: Indocyanine Green","Device: Near-Infrared Fluorescence Imaging System",[16,22],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"DRUG","Indocyanine Green","Indocyanine green (ICG), administered intravenously at a dose of 2.5 mg\u002Fml, will be used during surgery to evaluate bowel anastomosis perfusion through near-infrared fluorescence imaging.",[9],null,{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":21},"DEVICE","Near-Infrared Fluorescence Imaging System","A near-infrared fluorescence imaging device will be used intraoperatively to visualize indocyanine green (ICG) fluorescence, assessing the perfusion of bowel anastomoses during gynecologic oncology surgery.",[9],[28,31],{"name":29,"affiliation":5,"role":30},"Samet Topuz, Prof.","STUDY_CHAIR",{"name":32,"affiliation":5,"role":33},"Yagmur Minareci, Assist. Prof.","STUDY_DIRECTOR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":21,"email":39},"Atahan Toyran, Medical Doctor","CONTACT","+905057146233","atahan.toyran@istanbul.edu.tr",{"name":32,"role":37,"phone":41,"phoneExt":21,"email":42},"+905053574361","dryagmurminareci@gmail.com",[44],{"facility":45,"status":21,"city":46,"state":46,"zip":47,"country":48,"countryCode":21,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Istanbul University, Istanbul Faculty of Medicine, Department of Gynecologic Oncology","Istanbul","34093","Turkey (Türkiye)",{"type":50,"coordinates":51},"Point",[52,53],28.94966,41.01384,{"lat":53,"lon":52},[56,57,59,60],{"name":32,"role":37,"phone":41,"phoneExt":21,"email":42},{"name":36,"role":58,"phone":21,"phoneExt":21,"email":21},"SUB_INVESTIGATOR",{"name":32,"role":58,"phone":21,"phoneExt":21,"email":21},{"name":29,"role":61,"phone":21,"phoneExt":21,"email":21},"PRINCIPAL_INVESTIGATOR",{"type":61,"investigatorFullName":63,"investigatorTitle":64,"investigatorAffiliation":5,"oldNameTitle":21,"oldOrganization":21},"Atahan Toyran","Principal Investigator","100583089","phase-4-near-infrared-fluorescence-imaging-with-indocyanine-green-to-evaluate-bowel-anastomoses-in-gynecologic-oncology-surgery-100583089",false,"NCT06871787","Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery","Evaluation of Bowel Anastomoses During Gynecologic Oncology Surgery Using Near-Infrared Fluorescence Imaging With Indocyanine Green","INOCA","Inclusion Criteria:\n\n* Female patients aged 18 years or older.\n* Diagnosis of gynecologic cancer (ovarian, endometrial, cervical, vulvar) requiring surgical treatment.\n* Planned bowel resection and anastomosis during gynecologic oncology surgery.\n* Ability and willingness to provide informed consent.\n\nExclusion Criteria:\n\n* Known allergy or hypersensitivity to indocyanine green (ICG).\n* Pregnancy or breastfeeding at the time of surgery.\n* Severe liver or kidney dysfunction limiting the use of ICG.","FEMALE","18 Years",{"count":76,"type":77},50,"ESTIMATED","INTERVENTIONAL",[80],"PHASE4","The goal of this study is to evaluate if indocyanine green (ICG) fluorescence imaging helps reduce complications in bowel surgery performed during gynecologic cancer operations.\n\nThe main question it aims to answer is: Does using ICG fluorescence imaging during bowel anastomosis reduce the rate of complications such as leaks, infections, and abscesses within 30 days after surgery? Participants are women aged 18 and older undergoing surgery for gynecologic cancers (such as ovarian, uterine, cervical, or vulvar cancer). During surgery, investigators will inject ICG intravenously, then use a special near-infrared camera to see how well blood flows at the anastomosis site. The investigators will then decide if the reconnection is good enough or needs adjustment.\n\nResearchers will record any complications within the first 30 days after surgery to understand if this imaging method helps reduce surgical risks.",[83,84,85,86,87,88],"Gynecologic Cancers","Ovarian Cancer","Endometrial Cancers","Cervical Cancers","Vulvar Cancer","Anastomotic Leaks",[18,90,91,92,93,94],"Near-Infrared Imaging","Bowel Anastomosis","Gynecologic Oncology","Anastomotic Complications","Perfusion Assessment","NOT_YET_RECRUITING","2025-03-11",{"date":98,"type":99},"2025-03-14","ACTUAL",{"date":101,"type":77},"2025-09-01",{"date":103,"type":77},"2027-12-30",{"name":5,"class":6},1]